Timothy P. Gilliam

415 total citations
14 papers, 348 citations indexed

About

Timothy P. Gilliam is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Timothy P. Gilliam has authored 14 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Timothy P. Gilliam's work include Cancer, Lipids, and Metabolism (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Timothy P. Gilliam is often cited by papers focused on Cancer, Lipids, and Metabolism (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Timothy P. Gilliam collaborates with scholars based in United States and China. Timothy P. Gilliam's co-authors include Victoria Bae‐Jump, Chunxiao Zhou, J.E. Stine, Paola A. Gehrig, Hui Guo, Leslie H. Clark, Hannah M. Jones, Yajie Yin, Kenneth H. Kim and Amanda Jackson and has published in prestigious journals such as Journal of Hematology & Oncology, Oncotarget and Gynecologic Oncology.

In The Last Decade

Timothy P. Gilliam

12 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy P. Gilliam United States 9 220 176 74 73 45 14 348
Samina Dongol China 14 202 0.9× 266 1.5× 98 1.3× 42 0.6× 38 0.8× 17 463
Bárbara Oliva Chile 7 154 0.7× 102 0.6× 63 0.9× 82 1.1× 45 1.0× 13 271
Wenzhi Li China 15 274 1.2× 300 1.7× 41 0.6× 49 0.7× 53 1.2× 27 492
Qinyang Xu China 12 153 0.7× 248 1.4× 36 0.5× 37 0.5× 27 0.6× 19 398
Baoen Shan China 15 158 0.7× 296 1.7× 173 2.3× 63 0.9× 66 1.5× 46 516
Adam K. Willson United States 5 173 0.8× 210 1.2× 46 0.6× 36 0.5× 19 0.4× 8 325
Yuemei Jin China 11 180 0.8× 322 1.8× 76 1.0× 25 0.3× 19 0.4× 18 436
Sareena Singh United States 7 95 0.4× 194 1.1× 90 1.2× 20 0.3× 30 0.7× 10 332
Yajuan Su China 11 97 0.4× 192 1.1× 78 1.1× 25 0.3× 21 0.5× 24 327
M Umemoto Japan 5 103 0.5× 266 1.5× 134 1.8× 33 0.5× 27 0.6× 8 354

Countries citing papers authored by Timothy P. Gilliam

Since Specialization
Citations

This map shows the geographic impact of Timothy P. Gilliam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy P. Gilliam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy P. Gilliam more than expected).

Fields of papers citing papers by Timothy P. Gilliam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy P. Gilliam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy P. Gilliam. The network helps show where Timothy P. Gilliam may publish in the future.

Co-authorship network of co-authors of Timothy P. Gilliam

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy P. Gilliam. A scholar is included among the top collaborators of Timothy P. Gilliam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy P. Gilliam. Timothy P. Gilliam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Zhou, Chunxiao, Sun Li, Victoria Bae‐Jump, et al.. (2020). Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer. UNC Libraries. 2 indexed citations
2.
Jackson, Amanda, Chunxiao Zhou, Leslie H. Clark, et al.. (2020). Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer. UNC Libraries.
3.
Guo, Hui, Wei­min Kong, Lu Zhang, et al.. (2019). Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.. PubMed. 9(10). 2170–2193. 46 indexed citations
4.
Guo, Hui, Chunxiao Zhou, Victoria Bae‐Jump, et al.. (2019). NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo. UNC Libraries.
5.
Sun, Li, Yajie Yin, Leslie H. Clark, et al.. (2017). Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer. Oncotarget. 8(38). 63551–63561. 38 indexed citations
6.
Jackson, Amanda, Wenchuan Sun, Hui Guo, et al.. (2017). Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer. Oncotarget. 8(59). 100113–100127. 25 indexed citations
7.
Jones, Hannah M., Zhou Fang, Wenzheng Sun, et al.. (2017). Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro.. PubMed. 7(12). 2478–2490. 41 indexed citations
8.
Zhang, Lu, Jianjun Han, Amanda Jackson, et al.. (2016). NT1014, a novel biguanide, inhibits ovarian cancer growth in vitro and in vivo. Journal of Hematology & Oncology. 9(1). 91–91. 17 indexed citations
9.
Jackson, Amanda, Leslie H. Clark, Hui Guo, et al.. (2016). Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells.. PubMed. 8(6). 2705–15. 17 indexed citations
10.
Guo, Hui, Yan Zhong, Amanda Jackson, et al.. (2016). Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer. Oncotarget. 7(15). 20338–20356. 14 indexed citations
11.
Stine, J.E., Hui Guo, Xiugui Sheng, et al.. (2015). The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer. Oncotarget. 7(1). 946–960. 71 indexed citations
12.
Stine, J.E., Xiaobing Han, Chunxiao Zhou, et al.. (2014). The HMG-CoA reductase inhibitor simvastatin exhibits antitumorigenic and antimetastatic effects in ovarian cancer. Gynecologic Oncology. 133. 111–112. 4 indexed citations
13.
Gilliam, Timothy P., J.E. Stine, Chunxiao Zhou, et al.. (2014). Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer. Gynecologic Oncology. 134(2). 346–355. 69 indexed citations
14.
Stine, J.E., et al.. (2014). Simvastatin, an HMG-CoA reductase inhibitor, exhibits antimetastatic and antitumorigenic effects in endometrial cancer. Gynecologic Oncology. 133. 112–112. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samina Dongol Breakdown of academic impact, for papers by Bárbara Oliva Breakdown of academic impact, for papers by Wenzhi Li Breakdown of academic impact, for papers by Qinyang Xu Breakdown of academic impact, for papers by Baoen Shan Breakdown of academic impact, for papers by Adam K. Willson Breakdown of academic impact, for papers by Yuemei Jin Breakdown of academic impact, for papers by Sareena Singh Breakdown of academic impact, for papers by Yajuan Su Breakdown of academic impact, for papers by M Umemoto
Rankless by CCL
2026